XIANJU PHARMA is the leading steriod supplier in China.
XIANJU PHARMA focuses on providing services such as FDF, API, CMO,mainly producing sex hormone drugs, corticosteroid drugs, respiratory drugs, anesthetic drugs, and drug-device combination drugs.
FDA cGMP
WHO GMP
TGA PIC/S
ICH Q7
China GMP
EU GMP
Contact Us
We are one of the leading suppliers of steroid APIs and finished formulations in the global pharmaceutical market.
Xianju Pharmaceutical (Hong Kong) Limited and Zhejiang Xianju Pharmaceutical Sales Co., Ltd. are both subsidiaries of Zhejiang Xianju Pharmaceutical Co., Ltd.
Zhejiang Xianju Pharmaceutical Co., Ltd. (formerly Xianju Pharmaceutical Plant) was founded in 1972.Upholds the corporate mission of “our sincerity and responsibility for your health and happiness”.Follows the development vision of “becoming one of the top ten steroid drug suppliers in the world”.Adheres to the core values of “integrity, striving, openness, studiousness, responsibility, and win-win”.Ofers exclusive products under the business pattern of integrating APIs and preparations.Works intensively and meticulously for 50+ years in steroid hormone R&D in four major therapeutic fields (gynecology, anesthesiology, respiratory, and corticosteroids)
Details Determine Quality
comprehensively support our overseas formulation export business, ensuring raw material supply, compliant formulation production, and capacity layout. We provide global customers with high-quality products and stable supply chain services that meet international standards.
Value
Corporate Mission
Business Philosophy
Value
Corporate Mission
Business Philosophy
Why Choose XIANJU
At XIANJU PHARMA, we follows the development vision of “becoming one of the top ten steroid drug suppliers in the world”.Works intensively and meticulously for 50+ years in steroid hormone R&D in four major therapeutic fields (gynecology, anesthesiology, respiratory, and corticosteroids)
Sales
Achievements
XIANJU PHARMA annual revenue has exceeded 40 billion, with its overseas business experiencing explosive growth. The core preparation, prednisolone tablets, has successfully captured the U.S. market, securing the second-largest market share. This achievement marks our possession of core competitiveness in high-barrier international markets as we accelerate our march toward becoming one of the top ten global steroid suppliers.
Global Product
Status
This outstanding performance stems from our global sales footprint: our APIs are exported to dozens of countries across Europe, the Americas, and Asia, establishing a solid trade network. At the same time, high-quality finished dosage forms (FDFs) in four major therapeutic areas have been approved and launched in multiple countries worldwide. This dual-driven global sales landscape of “API + FDF” provides core support for the continued growth of our overseas sales.
Supply
Capabilities
We solidify our global market share with strong supply security. Leveraging API self-sufficiency and automated production advantages, we possess high supply chain resilience, enabling us to confidently respond to global emergency procurement needs while ensuring flexible delivery and stable supply.
Company
News & Blog
Hundreds of clients are thriled by the service that we deliver and are happy to tell us. Read about what some have said about us here.
Breakthrough! Xianju Pharmaceutical’s formulation product receives its first FDA approval in the United States
Request a Quote
Have Questions for Us ?
Fill One The Form and An Agent Will Reach Out to You.
Please give us a call, drop us an email or fill out the contact form and we’ll get back to you.
